- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CreoSG Co Ltd (040350)
The CreoSG share price today is 8,740, view KQ 040350 stock exchange data. Track the latest CreoSG share price with real-time updates on 040350 stock performance including market cap, day range, 52-week range and dividend yield. Access 040350 charts, earnings dates and analyst estimates to support your investment decisions.
KOSDAQ
Currency in KRW
8,740
-660(-7.02%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,430
9,270
52 wk Range
236
12,800
040350 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8,4309,270
52 wk Range
23612,800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
040350 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
15-05-2026
EPS / Forecast
-19.54 / --
Revenue / Forecast
2.63B / --
Compare 040350 to Peers and Sector
Metrics to compare | 040350 | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship Relationship040350PeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.9x | 1.2x | 12.5x | |
PEG Ratio | −0.44 | 0.02 | 0.01 | |
Price/Book | 3.7x | 0.7x | 2.4x | |
Price / LTM Sales | 14.8x | 0.8x | 2.3x | |
Upside (Analyst Target) | - | 107.3% | 29.0% | |
Fair Value Upside | Unlock | 47.4% | 5.6% | Unlock |
CreoSG Co.,Ltd., together with its subsidiaries, develops software solutions for financial institutions in South Korea. It operates through Solution, Product Distribution, and New Drug and Vaccine Development divisions. The company offers bank automation and network control system for Korea (BANCS-K). It also provides IT outsourcing services, including information system development; ERP development and operation; sales system development and operation; vehicle management system development and operation; and operation of website and shopping mall integrated management systems. In addition, the company distributes IT products, such as LED monitors, TV monitors, solid-state drives, computers, laptops, and printers. Further, it engages in the development, production, and sales of infectious disease vaccines, therapeutic vaccines, and vaccines developed for alternative routes of administration. The company develops its products based on its VSV vector technology. Its product pipeline includes SAV001, a product candidate in Phase 1 clinical trials to treat HIV/AIDS; and product candidates in preclinical trials for the treatment of COVID-19, hepatitis C, Ebola virus, MERS virus, Zika virus, and SFTS/HFRS. The company was formerly known as CUROCOM Co., Ltd. and changed its name to CreoSG Co.,Ltd. in March 2024. CreoSG Co.,Ltd. was founded in 1997 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the CreoSG (040350) Share Price Today?
The CreoSG share price today is 8,740.
What is the current CreoSG (040350) share price and day range?
As of 10-07-2026, the CreoSG share price is 8,740, with a previous close of 9,400. The share price has ranged from 8,430 to 9,270 today, while the 52-week range spans from 236 to 12,800.
What Is the CreoSG Market Cap?
As of today, CreoSG market cap is 183.12B.
What Is CreoSG's Earnings Per Share (TTM)?
The CreoSG EPS (TTM) is -385.
From a Technical Analysis Perspective, Is 040350 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does CreoSG Trade On?
CreoSG is listed and trades on the KOSDAQ.
What Is the Stock Symbol for CreoSG?
The stock symbol for CreoSG is "040350."
How Many Times Has CreoSG Stock Split?
CreoSG has split 10 times.
How Many Employees Does CreoSG Have?
CreoSG has 41 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.